Brickell Biotech, Inc. (FRTX) Tops Q1 EPS by 51c

Brickell Biotech, Inc. (NASDAQ: FRTX) reported Q1 EPS of ($1.14), $0.51 better than the analyst estimate of ($1.65).

For earnings history and earnings-related data on Brickell Biotech, Inc. (FRTX) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• RenovoRx regains Nasdaq minimum bid price compliance
• DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand